Hendershot Investments Inc. Has $298,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hendershot Investments Inc. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 571 shares of the medical equipment provider’s stock after selling 94 shares during the quarter. Hendershot Investments Inc.’s holdings in Intuitive Surgical were worth $298,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the fourth quarter valued at $82,517,000. Exome Asset Management LLC boosted its position in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. China Universal Asset Management Co. Ltd. grew its holdings in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares during the period. Finally, Consolidated Planning Corp lifted its stake in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ISRG has been the subject of several research analyst reports. Royal Bank of Canada upped their target price on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Truist Financial raised their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,940 shares of company stock valued at $3,333,485. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.9 %

Shares of ISRG stock opened at $582.98 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm’s 50 day moving average is $554.85 and its 200 day moving average is $513.96. The stock has a market capitalization of $207.65 billion, a P/E ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.